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ABSTRACT
Background: The purpose of the present work is two-fold: the frac-
tionation of Salvia officinalis essential oil and the cytotoxic study of
this oil with its fractions “in vitro” tumor cell lines. Materials and
Methods: S. officinalis essential oil was obtained by hydrodistillation
and fractionated with column chromatography; the essential oil and
its fractions were analyzed by gas chromatography (GC) coupled to
mass spectrometry (MS). The cytotoxic activity was evaluated in 
cellular lines of breast cancer MCF-7, colon cancer HCT-116, and
murine macrophage RAW264.7 cell lines by the MTT assay. Results:
the sub-subfraction F1.1.1 of S. officinalis essential oil containing α-
humulene present highest activity on RAW264.7 and HCT-116 with
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IC50 values of 41.9 and 77.3 μg/ml, respectively. The sub-subfraction
F1.2.1 of S. officinalis essential oil with trans-caryophyllene showed
less activity on RAW246.7 and HCT-116 with IC50 values of 90.5 and
145.8 μg/ml. Conclusion: This paper suggests that the α-humulene and
trans-caryophyllene extracted from S.officinalis essential oil inhibit tu-
mor cell growth.
Keywords: Salvia officinalis; cytotoxicity; sesquiterpenes; α-humu-
lene; trans-caryophyllene.
RESUMEN
Actividad citotóxica del α-humuleno y del tras-cariofileno de Salvia
officinalis en dos líneas celulares tumorales animal y humana
Antecedentes: Este trabajo tiene dos objetivos: el fraccionamiento
del aceite esencial de la especie Salvia officinalis y la determinación
de la citotoxicidad del mencionado aceite esencial con sus fracciones
en líneas celulares tumorales “in vitro”. Material y Métodos: El acei-
te esencial de Salvia officinalis fue obtenido por hidrodestilación y
fraccionado mediante cromatografía en columna; el aceite esencial y
sus fracciones fueron analizadas mediante cromatografía de gases
(GC) acoplada a espectrometría de masas (MS). La actividad citotó-
xica fue evaluada en líneas celulares de cáncer de mama MCF-7; cán-
cer de colon HCT-116 y en macrófago murino RAW264.7 con el ensa-
yo MTT. Resultados: La sub-subfracción F1.1.1 del aceite esencial de
Salvia officinalis que contiene alfa-humuleno presenta la actividad
mas acusada frente a las líneas celulares RAW264.7 y HCT-116, con
valores de IC50 de 41,9 y de 77,3 μg/ml respectivamente. La sub-sub-
fracción F1.2.1 del aceite esencial de Salvia officinalis con trans-ca-
riofileno, muestra menor actividad sobre células RAW246.7 y HCT-
116 con valores de IC50 de 90,5 y 145,8 μg/ml respectivamente.
Conclusión: Estos resultados sugieren que el alfa-humuleno y el trans-
cariofileno de los extractos del aceite esencial de Salvia officinalis in-
hiben el crecimiento de células tumorales.
Palabras Clave: Salvia officinalis; citotoxicidad; sesquiterpenos;
alfa-humuleno; trans-cariofileno.
ADIL EL HADRI Y COLS. AN. R. ACAD. NAC. FARM.
344
1.  INTRODUCTION
The generus Salvia L. (sage) of the family Lamiaceae is an aromat-
ic and medicinal plant and includes about 900 species spread through-
out the world. Salvia officinalis L. (S. officinalis), with the common ara-
bic name sâlma, sâlmiya or swak en-nâbi, is a native to the
Mediterranean region that is now extensively cultivated all over the
world (1). This plant has been known and utilized for hundreds of years
in natural medicine, due to its curative properties and good perform-
ance in combating various diseases. Recent publications have shown
some interesting features of its chemical composition, which is deter-
mined by its volatile (2) and nonvolatile compounds, and its applica-
tions in antibacterial (3), anti-inflammatory (4), antifungal (5), antivi-
ral (6), antioxidant activities (7) and clinical treatment of Alzheimer’s
disease (8). Terpenoids and phenolics have been identified as the two
major typical products of S. officinalis secondary metabolites (9).
Among the terpenoids, volatile oils have been largely investigated (9,
10) because of their broad range of applications to culinary, cosmetic,
pharmaceutical, and industrial fields. The essential oil composition of
Salvia species is highly influenced by genetic and environmental fac-
tors, climate conditions (11), season, and culture site (10, 12). The
strongest active constituents of sage are within its essential oil (1-2.8%),
comprising the monoterpenes α- and β-thujone, camphor, 1,8-cineole,
and borneol as well as the sesquiterpenes α-humulene and β-caryophyl-
lene in larger amounts; whereas the leaf contains di- and triterpenes,
as well (13). The compounds of the essential oils were divided into five
groups according to the amount of the major constituents (13):
1. camphor > α-thujone >1,8-cineole > β-thujone ((14) and our 
essential oil).
2. camphor > α-thujone > β-thujone > 1,8-cineole (15).
3. β-thujone > camphor > 1,8-cineole > α-thujone.
4. 1,8-cineole > camphor > α-thujone > β-thujone.
5. α-thujone > camphor > β-thujone > 1,8-cineole.
Moreover, many studies have reported antitumor activities of
Salvia species, especially for S. miltiorrhiza, and S. officinalis under in
vitro conditions (16, 17). In addition, S. officinalis has also a poten-
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tial in treating cancer “in vivo” as it shows strong antitumorigenic ac-
tivities in mice (18).
In this study, we report the chemical composition of S. officinalis
collected in the north-west of Morocco. The leaf essential oil and its
active fractions, subfractions and sub-subfractions obtained were in-
vestigated by gas chromatography (GC) and GC/mass spectrometry
(GC-MS) analysis. They were tested against two human cancer cell
lines (HCT-116, MCF-7) and murine macrophage cell line (RAW264.7)
under in vitro conditions.
2.  MATERIALS AND METHODS
2.1.  Essential oil
The leaves of S. officinalis plant were collected in Tétouan area,
north-west of Morocco in June 2008. The botanical identification of
Salvia plant and the extraction of essential oil were realized in the
Biology and Health laboratory of the Département de Biologie,
Université Abdelmalek Essaâdi Tétouan. Two thousand grams of fresh
material were submitted to hydrodistillation for 3 h using a Clevenger-
type apparatus. The white-yellow essential oil was dried over anhy-
drous sodium sulphate and stored at 4 ºC.
2.2.  Fractionation of S. officinalis essential oil
Column chromatography was used for the fractionation of the es-
sential oil. Fifteen grams of the S. officinalis essential oil was fraction-
ated using a column chromatography (1.5 cm× 500 cm) packed with
100 g of silica gel 60, equilibrated with hexan. The column was elut-
ed successively with 250 ml each of n-hexan (100), n-hexan-ethyl ac-
etate (95/5, 90/10, 85/15, 75/25, 50/50, 20/80, 10/90), ethyl acetate (100),
and methanol. The organic solvents were removed from the eluates by
evaporation under reduced pressure to get nine fractions (F1-F9). The
first fraction F1 showed a significant cytotoxic activity and was fur-
ther fractionated (Table 2). First by preparative thin-layer chromatog-
raphy (TLC) and achieved using silica gel 60-F254-precoated plates
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(Merck) with heptane (100) as the mobile phase. The plates were re-
vealed by sparing with vanillin/ sulfuric acid reagent and subsequent
heating at 105 ºC. Three subfractions were obtained (F1.1, F1.2 and
F1.3); the subfractions F1.1 and F1.2 showed a cytotoxic activity in the
three cell lines (Table 2). In the same way, the two active subfractions
were fractionated again with TLC analysis in silica plates with
toluene/ethyl acetate (97/3) as mobile phase, and two sub-subfractions
F1.1.1 and F1.2.1 were selected from the subfractions F1.1 and F1.2
respectively.
2.3.  Gas Chromatography-Mass Spectrometry (GC-MS) analysis
GC-MS analysis of the essential oil S. officinalis and of its active
fractions was carried out using a Hewlett-Packard 7890 gas chromato-
graph equipped with a methylpolysiloxane capillary column (30 m
length, 0.25 mm internal diameter, 0.25 film thickness) coupled to a
Hewlett Packard 5975C mass spectrometer. Ionization of the sample
components was performed in electron impact mode (EI, 70 eV). The
carrier gas was helium (5psi, 0.7ml/min) and the temperature pro-
gram was 70 ºC for 2min, then 6 ºC/min to 270 ºC and held constant
for 20 min. 1 μl of a hexane solution at 0.2-1% was injected in the
split mode. Volatile components were identified from their retention
data and their mass spectra, which were compared with reference data
(Wiley mass spectral library). Relative amount was estimated from to-
tal ion current peak area.
2.4.  Cancer cell lines
The colorectal adenocarcinoma human cell line (HCT-116), human
breast cancer cell (MCF-7) and murine macrophage cell line (RAW264.7)
were cultured in RPMI-1640 medium (+)L-glutamin, supplemented with
10% foetal bovine serum, 1% penicillin/streptomycin, 2 mg of gentam-
icin, 1% sodium pyruvate 100 mM (Invitrogen-Gibco, Madrid, Spain)
and 1% D-(+) glucose solution (45%) (Sigma-Aldrich, Madrid, Spain).
Cells were cultured in a humidified atmosphere at 37 ºC in 5% CO2. The
cultures were passed twice a week by trypsinization using a trypsin-
EDTA (0.05%) solution (Invitrogen-Gibco, Madrid, Spain).
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2.5.  Chemicals
1,8-cineole, α-thyjone, β-thyjone, α-humulene, trans-caryophyl-
lene, tamoxifen and different solvents were purchased from Sigma-
Aldrich, Madrid, Spain.
2.6.  Measurement of viability using the MTT Assay
Cytotoxicity was assessed using the microtitration colorimetric method
of MTT reduction test as described by Mosmann in 1983 (19). The cells
were trypsinized, counted and placed in 96-well plates at optimal plating
density of each cell line which was determined over a range from 5x104
to 10x104. After 24 h, the cells were treated with serial dilutions of the
samples. Each sample was initially dissolved in dimethyl sulphoxide
(DMSO) and further diluted in medium to produce different concentra-
tions. One hundred microliters/ well of each dilution were added to the
plates in six replicates to obtain the final concentrations ranging from 12.5
to 800 μg/ml for whole essential oil, their active fractions, subfractions and
sub-subfractions, from 1.56 to 100 μg/ml for the commercially available
identified constituents (1,8-cineole, β-thyjone, α-humulene, trans-
caryophyllene). All compounds were dissolved in DMSO and the final con-
centration of DMSO in the culture medium was maintained at 0.5% (v/v).
Cytotoxic activity of these compounds was expressed as the concentration
of drugs inhibiting cell growth by 50% (IC50). Fluorescence was measured
on the automated 96-well plate reader at 550 nm. Tamoxifen (Sigma-
Aldrich, Madrid, Spain) was used as positive control.
2.7.  Statistical analysis
All experiments were carried out in triplicate. Data were expressed
as means ± S.D. Differences were evaluated by the one-way analysis
of variance (ANOVA) test completed by a multicomparison Dunett’s
test. Differences were considered significant at (*P < 0.05). The IC50
was calculated by a nonlinear regression curve with the use of Prism
GraphPad Prism version 5.0 software for Windows. The dose-response
curve was obtained by plotting the percentage of inhibition versus the
concentrations.
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3.  RESULTS
3.1.  Essential oil, active fractions, subfractions and sub-subfractions
compositions
In order to identify active compounds present within the essential
oil and its active subfractions, gas chromatography systems were 
applied. The chemical composition of the essential oil and its fractions,
subfractions and sub-subfractions is shown in Table 1. S. officinalis es-
sential oil was characterized by 23 compounds (98% of the total oil)
of which 18 were monoterpenes, 4 sesquiterpenes and diterpene. The
GC-MS analysis revealed the presence of camphor (21.23%), α-thujone
(21.22%), 1,8-cineole (17.52%), β-thujone (13.45%), trans-caryophyl-
lene (1.67%) and α-humulene (1.45%). The fractions F1, F2 and F3 rep-
resent respectively 92.67%, 96.67% and 91% of the total compounds
identified. In the fraction F1, the main compounds were α-pinene
(18.56%), trans-caryophyllene (18.32%), camphene (14.81%) and α-hu-
mulene (12.38%). In the F2 and F3 fractions the main compounds were
α-thujone and 1,8-cineole with 67.05%, 10.88% and 49.06%, 20.72%
respectively.
3.2.  Cytotoxicity
The cytotoxicity of the essential oil of S. officinalis and its frac-
tions in the three cancer cell lines is shown in Figures 1, 2 and 3,
and the IC50 values are given in Table 2. The first fraction F1 was the
most active on the murine macrophage cells RAW264.7 (IC50 118.4
μg/ml). Less activity was found when the fraction F1 was applied to
both cell cultures (279.3 and 265.5 μg/ml for HCT-116 and MCF-7,
respectively). The sub-subfraction (ssf) F1.1.1 obtained from subfrac-
tion (sf) F1.1 was more active on the RAW264.7 cells (IC50 41.9 μg/ml)
than on the HCT-116 cells (IC50 77.3 μg/ml). Less activity was found
when the ssf F1.1.1 was applied to MCF-7 cells (IC50 125.7 μg/ml).
The ssf F1.2.1 selected from sf F1.2 was less cytotoxic in RAW264.7
(IC50 90.5 μg/ml), HCT-116 (IC50 145.8 µg/ml) and MCF-7 (IC50 144.7
μg/ml). Commercially available samples of some of the identified
main compounds (1,8-cineole, β-thujone, trans-caryophyllene and α-
humulene) were tested for their cytotoxic activity in vitro on the three
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cancer cells, in order to identify and compare the active oil con-
stituents. Interestingly, trans-caryophyllene exerted cytotoxic activity
on HCT-116 (IC50 65.2 μg/ml) and was more active against RAW264.7
(IC50 35.2 μg/ml), but in the MCF-7 cells it showed less cytotoxicity
(IC50 > 100 μg/ml). The results also indicated that α-humulene was
active in a similar manner against HCT-116 and MCF-7 cell lines with
IC50 values of 64.2 μg/ml and 81.9 μg/ml, and the highest cytotoxic
activity of this constituent (IC50 38.4 μg/ml) was found in the
RAW264.7 cells.
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Table 2.  Cytotoxic activity of S. officinalis, its fraction and subfraction samples.
IC50 in μg/ml.
Essential oil,
fractions and
subfractions
Cell line
HCT-116 MCF-7 RAW264.7
Salvia officinalis L. 394.6 ± 1.4 *          554.4 ± 1.5 207.5 ± 0.8 **     
Fraction F1 279.3 ± 3.6 **    265.5 ± 4,4 ** 139.5 ± 0.6 *** 
Subfraction F1.1 217.4 ± 7.4 **    213.1 ± 7.1 ** 118.4 ± 2,5 ***
Subfraction F1.2 145.2 ± 0.6 **    139.7 ± 6 **          101.8 ± 4.7 ***
Subfraction F1.3 371 ± 4.4 * > 400 264.9 ± 3.1 *
Fraction F2 316.6 ± 6.6 **    444.3 ± 12.6 * 163.7 ± 2.5 ***
Fraction F3 423 ± 6.3 * 514.4 ± 11 143.8 ± 3.8 ***
Fraction F4 > 800 556.9 ± 13 > 400
Fraction F5 > 800 > 800 > 400
Fraction F6 > 800 > 800 > 400
Fraction F7 > 800 > 800 > 400
Fraction F8 > 800 > 800 > 400
Fraction F9 > 800 > 800 > 400
Data are given as the mean ± S.D (three independent experiments). Significantly different from control
at *p < 0.05, **p < 0.01 and ***p < 0.001, respectively.
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Figure 2.  Cytotoxic activity (%) of S. officinalis essential oil and its fractions in
a dose-dependent pattern (12.5- 800 μg/ml) for the MCF-7 breast cancer cell line.
Values are expressed as mean ± S.D of three independent experiments in triplicate.
Figure 1.  Cytotoxic activity (%) of S. officinalis essential oil and its fractions in
a dose-dependent pattern (12.5- 800 μg/ml) for the HCT-116 colon cancer cell line.
Values are expressed as mean ± S.D of three independent experiments in triplicate.
4.  DISCUSSION
In our study S. officinalis leaf essential oil was analysed with CG-
MS and fractionated to identify the mainly cytotoxic compounds in
cancer cell lines. This species has been extensively investigated for its
chemical composition and pharmacological profile. Some diterpenoid
quinones (royleanone-SAR 3, horminone-SAR 26, and horminone-SAR
43) isolated from the roots of S. officinalis are able to induce cytotox-
ic and DNA-damaging activity in human colon carcinoma Caco-2 cells
and human hepatoma HepG2 cells in vitro conditions (20).
In the ssf F1.1.1, the main compound identified was α-humulene
(81.47%) which exhibited high cytotoxic activity in the murine
macrophage cells, colorectal adenocarcinoma cells and breast
melanoma cells. These results were in accordance with other data
which showed that the sesquiterpene fraction of S. officinalis with
the presence of α-humulene, demonstrate a strong cytotoxic activi-
ty in human prostate carcinoma LNCaP cells (21). In the same way,
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Figure 3.  Cytotoxic activity (%) of S. officinalis essential oil and its fractions
in a dose-dependent pattern (12.5- 800 μg/ml) for the RAW264.7 breast cancer
cell line. Values are expressed as mean ± S.D of three independent experiments in
triplicate.
a previous study reported the cytotoxic activity of α-humulene on
PC-3, A-549, DLD-1 and M4BEU tumor cells through glutathione de-
pletion and reactive oxygen species production (22). Similarly, our
results showed the production of reactive oxygen species in
sesquiterpene sub-subfractions (F1.1.1, F1.2.1) and commercial
compounds: α-humulene and trans-caryophyllene (data not shown).
The ssf F1.2.1 contained trans-caryophyllene (54.23%) as the main
compound and presented less cytotoxicity than ssf F1.1.1 in the three
cell lines tested. In some works, the sesquiterpenes α-humulene and
trans-caryophyllene are the main active compounds responsible for
the anti-inflammatory actions displayed by the essential oil of Cordia
verbenacea (23). However, the in vivo study of α-humulene adminis-
tered orally to mice was rapidly transported to several important tis-
sues and it was found markedly reduced in some possible inactive
mono and di-epoxides (24).
In the present study, the observed variation in cytotoxic activities
of the fractions, subfractions and sub-subfractions, can be explained
by the sensitivity of the cell line studied. The comparaison of results
from all S. officinalis samples indicates that MCF-7 cells are more re-
sistant than HCT-116 cells, whereas RAW264.7 cells are still more sen-
sitive. Furthermore, the comparison of cytotoxic activity data with the
chemical composition of the fractions F1, F2 and F3 of essential oil
S. officinalis showed that 1,8-cineole and β-thujone were absent in the
first fraction F1 which was highly cytotoxic, and both compounds
were present in the fractions F2 and F3 (10.87%, 67.05% and 20.72%,
49.06% respectively) with less cytotoxic activity. This observation con-
firmed that 1,8-cineole and β-thujone were not responsible for the cy-
totoxicity of our essential oil in all cell lines studied.
5.  CONCLUSION
The sesquiterpenes α-humulene and trans-caryophyllene were
the main compounds of our sub-subfractions from the essential oil
S. officinalis and had the ability to inhibit cancer cell growth. In
addition, these data suggest that more analysis of the pharmacoki-
netic parameters of active compounds are necessary before starting
the clinical trials.
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